Enanta Pharmaceuticals Inc
General ticker "ENTA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $162.6M
Enanta Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -11.4%.
Estimated limits based on current volatility of 5.2%: low 5.59$, high 6.20$
Factors to consider:
- Current price 16.4% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [7.62$, 17.16$]
- 2025-09-30 to 2026-09-30 estimated range: [9.15$, 19.10$]
Short-term ENTA quotes
Long-term ENTA plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $86.16MM | $79.20MM | $67.64MM |
| Operating Expenses | $210.00MM | $216.41MM | $189.33MM |
| Operating Income | $-123.84MM | $-137.21MM | $-121.69MM |
| Non-Operating Income | $1.66MM | $6.21MM | $3.90MM |
| Interest Expense | $1.57MM | $5.15MM | $10.94MM |
| R&D Expense | $164.52MM | $163.52MM | $131.48MM |
| Income(Loss) | $-122.19MM | $-131.00MM | $-117.79MM |
| Taxes | $-0.43MM | $2.82MM | $-1.74MM |
| Profit(Loss) | $-121.75MM | $-133.82MM | $-116.05MM |
| Stockholders Equity | $321.33MM | $216.74MM | $128.81MM |
| Assets | $375.41MM | $462.27MM | $376.65MM |
| Operating Cash Flow | $-84.78MM | $-103.15MM | $-78.76MM |
| Capital expenditure | $2.12MM | $9.06MM | $17.95MM |
| Investing Cash Flow | $54.90MM | $-53.58MM | $58.23MM |
| Financing Cash Flow | $20.03MM | $198.13MM | $-27.63MM |
| Earnings Per Share* | $-5.91 | $-6.38 | $-5.48 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.